Editorial Perspectives On Data Management & Analysis

  1. A New Pain Treatment Requires Accurate And Reliable Data 9/21/2022

    South Rampart Pharma aims to deliver a new, affordable treatment for pain that will avoid the issues with currently marketed products. Opioids are highly addictive; patients taking excessive amounts of acetaminophen can develop liver toxicity; and NSAID over-exposure risks kidney toxicity, gastrointestinal (GI) bleeding, and worsening of high blood pressure in patients with hypertension.

  2. Walgreens Is Ready To Re-Envision Recruitment, DCTs, And RWE 9/12/2022

    Since becoming CEO of Walgreens Boots Alliance (WBA) in March 2021, Rosalind Brewer has been focused on healthcare and what the company could do to help its patients. WBA refers to the integrated healthcare, pharmacy, and retail store that currently serves millions of customers and patients every day. This past June, the company launched its clinical trial business. 

  3. How Is The Role Of Clinical Data Manager Changing? 8/30/2022

    The results of a study are only as good as the data collected. For that reason, clinical data managers (CDMs) are often the unsung heroes of clinical trials. Those managers must ensure the collected data is accurate, while avoiding tainted data that can endanger patients, studies, and the reputations of the companies conducting the research.

  4. Clinical Trials Enter A New Digital Era 11/17/2021

    The life sciences industry has been undergoing a transformation. Its seen advancements in how therapies are developed and improvements in how the industry works together. One development that has helped the industry evolve is the shift to digital technologies.

  5. How Real-World Data Will Advance Oncology Clinical Trials 10/28/2021

    Real-world data (RWD) is coming to fruition in clinical trials. One area where it is expected to have a huge impact on innovation is oncology studies. This topic was discussed by a panel of experts at The Future of Health Data conference hosted by Datavant.

  6. Data Liquidity: Privacy, Ethics, And Patient Benefit 10/26/2021

    There has been a push in recent years to increase the liquidity of patient data and make that data more accessible to the patients from whom it was gathered. But increasing the liquidity of data also increases concerns around privacy and ethics.

  7. Can Smarter Study Design Relieve The Recruitment Challenge? 9/18/2021

    Recruitment has always been a challenge for companies conducting clinical trials. Sponsor companies seeking new ways to engage and recruit patients have seen varied success. But could that challenge be mitigated or eliminated with smarter study design?

  8. How Otsuka Uses Decentralized Trials & Real-World Evidence 8/3/2021

    Prior to joining Otsuka in 2019, Christoph Koenen spent two years with GSK, 10 years with Novo Nordisk, and eight years with BMS. I recently spoke to him about some of the key lessons he’s learned over the years and how Otsuka is applying new clinical trial strategies and technologies, especially for the treatment of patients in mental health trials.

  9. Is AI Improving Outcomes In Clinical Trials? 1/21/2021

    In October 2020, I hosted a webinar on the topic of AI and how it will improve outcomes in clinical trials. This article highlights some of the comments from that discussion.

  10. A New Technology Takes Alkermes Into Oncology 10/6/2020

    Moving into a new therapeutic area is a difficult proposition for most companies. That is not news to Blair Jackson. Jackson, the SVP of corporate planning at Alkermes, has been with the company for more than 21 years and knows the challenges of moving into research on new diseases.